Zinc in PDB 1g49: A Carboxylic Acid Based Inhibitor in Complex with MMP3
Enzymatic activity of A Carboxylic Acid Based Inhibitor in Complex with MMP3
All present enzymatic activity of A Carboxylic Acid Based Inhibitor in Complex with MMP3:
3.4.24.17;
Protein crystallography data
The structure of A Carboxylic Acid Based Inhibitor in Complex with MMP3, PDB code: 1g49
was solved by
M.G.Natchus,
R.G.Bookland,
B.De,
N.G.Almstead,
S.Pikul,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
19.70 /
1.90
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
37.668,
77.112,
106.145,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
n/a /
25.3
|
Other elements in 1g49:
The structure of A Carboxylic Acid Based Inhibitor in Complex with MMP3 also contains other interesting chemical elements:
Zinc Binding Sites:
The binding sites of Zinc atom in the A Carboxylic Acid Based Inhibitor in Complex with MMP3
(pdb code 1g49). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 4 binding sites of Zinc where determined in the
A Carboxylic Acid Based Inhibitor in Complex with MMP3, PDB code: 1g49:
Jump to Zinc binding site number:
1;
2;
3;
4;
Zinc binding site 1 out
of 4 in 1g49
Go back to
Zinc Binding Sites List in 1g49
Zinc binding site 1 out
of 4 in the A Carboxylic Acid Based Inhibitor in Complex with MMP3
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of A Carboxylic Acid Based Inhibitor in Complex with MMP3 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn301
b:19.1
occ:1.00
|
NE2
|
A:HIS205
|
2.1
|
12.5
|
1.0
|
NE2
|
A:HIS201
|
2.1
|
15.2
|
1.0
|
NE2
|
A:HIS211
|
2.4
|
26.3
|
1.0
|
CD2
|
A:HIS201
|
3.0
|
12.0
|
1.0
|
CE1
|
A:HIS205
|
3.1
|
12.2
|
1.0
|
CD2
|
A:HIS205
|
3.1
|
12.6
|
1.0
|
CD2
|
A:HIS211
|
3.1
|
26.2
|
1.0
|
CE1
|
A:HIS201
|
3.2
|
14.5
|
1.0
|
CE1
|
A:HIS211
|
3.4
|
23.7
|
1.0
|
CG
|
A:HIS201
|
4.2
|
14.4
|
1.0
|
ND1
|
A:HIS205
|
4.2
|
11.5
|
1.0
|
CG
|
A:HIS205
|
4.2
|
14.2
|
1.0
|
ND1
|
A:HIS201
|
4.3
|
14.6
|
1.0
|
CG
|
A:HIS211
|
4.3
|
24.1
|
1.0
|
ND1
|
A:HIS211
|
4.3
|
24.0
|
1.0
|
CE
|
A:MET219
|
4.7
|
12.0
|
1.0
|
O
|
A:HOH364
|
4.7
|
20.8
|
1.0
|
OE2
|
A:GLU202
|
4.7
|
14.2
|
1.0
|
OE1
|
A:GLU202
|
4.9
|
18.1
|
1.0
|
|
Zinc binding site 2 out
of 4 in 1g49
Go back to
Zinc Binding Sites List in 1g49
Zinc binding site 2 out
of 4 in the A Carboxylic Acid Based Inhibitor in Complex with MMP3
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of A Carboxylic Acid Based Inhibitor in Complex with MMP3 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn302
b:15.9
occ:1.00
|
ND1
|
A:HIS179
|
2.0
|
16.1
|
1.0
|
OD2
|
A:ASP153
|
2.0
|
14.6
|
1.0
|
NE2
|
A:HIS166
|
2.0
|
13.4
|
1.0
|
NE2
|
A:HIS151
|
2.1
|
15.4
|
1.0
|
CE1
|
A:HIS179
|
2.9
|
13.5
|
1.0
|
CD2
|
A:HIS151
|
3.0
|
15.4
|
1.0
|
CG
|
A:ASP153
|
3.0
|
18.2
|
1.0
|
CG
|
A:HIS179
|
3.0
|
14.7
|
1.0
|
CD2
|
A:HIS166
|
3.0
|
12.9
|
1.0
|
CE1
|
A:HIS166
|
3.0
|
11.7
|
1.0
|
CE1
|
A:HIS151
|
3.1
|
15.9
|
1.0
|
OD1
|
A:ASP153
|
3.3
|
16.8
|
1.0
|
CB
|
A:HIS179
|
3.4
|
14.3
|
1.0
|
NE2
|
A:HIS179
|
4.0
|
14.3
|
1.0
|
CD2
|
A:HIS179
|
4.1
|
14.7
|
1.0
|
ND1
|
A:HIS166
|
4.1
|
12.2
|
1.0
|
CG
|
A:HIS151
|
4.1
|
16.0
|
1.0
|
CG
|
A:HIS166
|
4.2
|
13.7
|
1.0
|
ND1
|
A:HIS151
|
4.2
|
16.0
|
1.0
|
CB
|
A:ASP153
|
4.3
|
18.6
|
1.0
|
OH
|
A:TYR168
|
4.4
|
15.5
|
1.0
|
O
|
A:TYR155
|
4.4
|
16.0
|
1.0
|
CE1
|
A:TYR168
|
4.6
|
13.0
|
1.0
|
CZ
|
A:PHE157
|
4.7
|
16.3
|
1.0
|
CE1
|
A:PHE157
|
4.8
|
16.0
|
1.0
|
CA
|
A:HIS179
|
4.9
|
14.4
|
1.0
|
O
|
A:HOH319
|
4.9
|
14.3
|
1.0
|
CZ
|
A:TYR168
|
4.9
|
15.7
|
1.0
|
|
Zinc binding site 3 out
of 4 in 1g49
Go back to
Zinc Binding Sites List in 1g49
Zinc binding site 3 out
of 4 in the A Carboxylic Acid Based Inhibitor in Complex with MMP3
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 3 of A Carboxylic Acid Based Inhibitor in Complex with MMP3 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn801
b:24.6
occ:1.00
|
OA
|
B:111901
|
1.9
|
38.1
|
1.0
|
NE2
|
B:HIS711
|
2.1
|
26.7
|
1.0
|
NE2
|
B:HIS701
|
2.2
|
23.6
|
1.0
|
OB
|
B:111901
|
2.3
|
37.0
|
1.0
|
NE2
|
B:HIS705
|
2.3
|
19.0
|
1.0
|
NA
|
B:111901
|
2.8
|
38.4
|
1.0
|
C20
|
B:111901
|
2.9
|
38.7
|
1.0
|
CD2
|
B:HIS711
|
2.9
|
24.0
|
1.0
|
CD2
|
B:HIS701
|
3.0
|
21.5
|
1.0
|
CD2
|
B:HIS705
|
3.1
|
19.6
|
1.0
|
CE1
|
B:HIS711
|
3.3
|
23.7
|
1.0
|
CE1
|
B:HIS701
|
3.4
|
21.3
|
1.0
|
CE1
|
B:HIS705
|
3.4
|
21.2
|
1.0
|
O
|
B:HOH88
|
4.1
|
20.4
|
1.0
|
CG
|
B:HIS711
|
4.1
|
24.5
|
1.0
|
CG
|
B:HIS701
|
4.3
|
21.3
|
1.0
|
ND1
|
B:HIS711
|
4.3
|
24.3
|
1.0
|
OE2
|
B:GLU702
|
4.3
|
19.5
|
1.0
|
CG
|
B:HIS705
|
4.3
|
19.2
|
1.0
|
ND1
|
B:HIS701
|
4.4
|
20.5
|
1.0
|
C8
|
B:111901
|
4.4
|
38.0
|
1.0
|
ND1
|
B:HIS705
|
4.4
|
19.7
|
1.0
|
C9
|
B:111901
|
4.8
|
38.7
|
1.0
|
CE
|
B:MET719
|
4.9
|
19.0
|
1.0
|
C1
|
B:111901
|
5.0
|
36.1
|
1.0
|
C17
|
B:111901
|
5.0
|
40.4
|
1.0
|
C6
|
B:111901
|
5.0
|
35.7
|
1.0
|
OE1
|
B:GLU702
|
5.0
|
20.1
|
1.0
|
|
Zinc binding site 4 out
of 4 in 1g49
Go back to
Zinc Binding Sites List in 1g49
Zinc binding site 4 out
of 4 in the A Carboxylic Acid Based Inhibitor in Complex with MMP3
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 4 of A Carboxylic Acid Based Inhibitor in Complex with MMP3 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn802
b:17.4
occ:1.00
|
NE2
|
B:HIS651
|
2.0
|
15.3
|
1.0
|
NE2
|
B:HIS666
|
2.0
|
16.9
|
1.0
|
ND1
|
B:HIS679
|
2.1
|
15.5
|
1.0
|
OD2
|
B:ASP653
|
2.2
|
19.2
|
1.0
|
CE1
|
B:HIS666
|
2.9
|
17.1
|
1.0
|
CG
|
B:ASP653
|
2.9
|
17.9
|
1.0
|
CD2
|
B:HIS651
|
3.0
|
16.2
|
1.0
|
CE1
|
B:HIS651
|
3.1
|
15.6
|
1.0
|
CE1
|
B:HIS679
|
3.1
|
11.9
|
1.0
|
CG
|
B:HIS679
|
3.1
|
14.1
|
1.0
|
CD2
|
B:HIS666
|
3.2
|
17.3
|
1.0
|
OD1
|
B:ASP653
|
3.2
|
15.1
|
1.0
|
CB
|
B:HIS679
|
3.4
|
14.1
|
1.0
|
OH
|
B:TYR668
|
4.0
|
16.4
|
1.0
|
ND1
|
B:HIS666
|
4.1
|
17.5
|
1.0
|
CG
|
B:HIS651
|
4.1
|
16.0
|
1.0
|
ND1
|
B:HIS651
|
4.1
|
16.1
|
1.0
|
O
|
B:TYR655
|
4.2
|
16.4
|
1.0
|
NE2
|
B:HIS679
|
4.2
|
10.5
|
1.0
|
CG
|
B:HIS666
|
4.2
|
16.4
|
1.0
|
CD2
|
B:HIS679
|
4.2
|
13.8
|
1.0
|
CB
|
B:ASP653
|
4.3
|
17.4
|
1.0
|
CE1
|
B:TYR668
|
4.6
|
16.1
|
1.0
|
CZ
|
B:PHE657
|
4.6
|
15.8
|
1.0
|
CE1
|
B:PHE657
|
4.7
|
14.0
|
1.0
|
CZ
|
B:TYR668
|
4.8
|
18.4
|
1.0
|
CA
|
B:HIS679
|
5.0
|
14.7
|
1.0
|
|
Reference:
M.G.Natchus,
R.G.Bookland,
B.De,
N.G.Almstead,
S.Pikul.
Development of New Hydroxamate Matrix Metalloproteinase Inhibitors Derived From Functionalized 4-Aminoprolines. J.Med.Chem. V. 43 4948 2000.
ISSN: ISSN 0022-2623
PubMed: 11150165
DOI: 10.1021/JM000246E
Page generated: Sun Oct 13 01:19:44 2024
|